These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 34683370)
81. Induced Native Phage Cocktails for Multi-microbial Activation Syndrome in Treatment-Resistant Illnesses. Jernigan DA Cureus; 2024 Oct; 16(10):e72587. PubMed ID: 39474589 [TBL] [Abstract][Full Text] [Related]
82. Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through Campos DL; Canales CSC; Demarqui FM; Fernandes GFS; Dos Santos CG; Prates JLB; da Silva IGM; Barros-Cordeiro KB; Báo SN; de Andrade LN; Abichabki N; Zacharias LV; de Campos MMA; Dos Santos JL; Pavan FR Front Microbiol; 2024; 15():1487829. PubMed ID: 39464394 [TBL] [Abstract][Full Text] [Related]
83. Successful Use of Fecal Microbiota Transplantation in Management of Nonobstructive Recurrent Cholangitis Following Total Pancreatectomy and Islet Autotransplant. Scott A; Khoruts A; Freeman ML; Beilman G; Ramanathan K; Bellin MD; Trikudanathan G ACG Case Rep J; 2024 Oct; 11(10):e01527. PubMed ID: 39399248 [TBL] [Abstract][Full Text] [Related]
85. Antibacterial Mechanisms and Antivirulence Activities of Oridonin against Pathogenic Wang L; Li H; Chen J; Wang Y; Gu Y; Jiu M Microorganisms; 2024 Feb; 12(2):. PubMed ID: 38399819 [No Abstract] [Full Text] [Related]
86. Antibiofilm and Antivirulence Properties of 6-Polyaminosteroid Derivatives against Antibiotic-Resistant Bacteria. Vergoz D; Le H; Bernay B; Schaumann A; Barreau M; Nilly F; Desriac F; Tahrioui A; Giard JC; Lesouhaitier O; Chevalier S; Brunel JM; Muller C; Dé E Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38275318 [TBL] [Abstract][Full Text] [Related]
87. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. MacNair CR; Rutherford ST; Tan MW Nat Rev Microbiol; 2024 May; 22(5):262-275. PubMed ID: 38082064 [TBL] [Abstract][Full Text] [Related]
88. Isolation and functional analysis of phage-displayed antibody fragments targeting the staphylococcal superantigen-like proteins. Alanko I; Sandberg R; Brockmann EC; de Haas CJC; van Strijp JAG; Lamminmäki U; Salo-Ahen OMH Microbiologyopen; 2023 Aug; 12(4):e1371. PubMed ID: 37642487 [TBL] [Abstract][Full Text] [Related]
89. Preference of Bacterial Rhamnosyltransferases for 6-Deoxysugars Reveals a Strategy To Deplete O-Antigens. Harnagel AP; Sheshova M; Zheng M; Zheng M; Skorupinska-Tudek K; Swiezewska E; Lupoli TJ J Am Chem Soc; 2023 Jul; 145(29):15639-15646. PubMed ID: 37437030 [TBL] [Abstract][Full Text] [Related]
91. Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential. Escobar-Salom M; Barceló IM; Jordana-Lluch E; Torrens G; Oliver A; Juan C FEMS Microbiol Rev; 2023 Mar; 47(2):. PubMed ID: 36893807 [TBL] [Abstract][Full Text] [Related]
92. Quinate-based ligands for irreversible inactivation of the bacterial virulence factor DHQ1 enzyme-A molecular insight. Rodríguez Á; Maneiro M; Lence E; Otero JM; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C Front Mol Biosci; 2023; 10():1111598. PubMed ID: 36762206 [TBL] [Abstract][Full Text] [Related]
93. Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System. Lv C; Li Y; Wei Y; Wang J; Yu H; Gao F; Zhu C; Jia X; Tong M; Dong P; Gao Q; Geng L Molecules; 2022 Nov; 27(23):. PubMed ID: 36500441 [TBL] [Abstract][Full Text] [Related]
94. Antibody-Based Immunotherapies as a Tool for Tackling Multidrug-Resistant Bacterial Infections. Seixas AMM; Sousa SA; Leitão JH Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366297 [TBL] [Abstract][Full Text] [Related]
95. Antimicrobial and Antivirulence Activities of Carvacrol against Pathogenic Wang J; Qin T; Chen K; Pan L; Xie J; Xi B Microorganisms; 2022 Oct; 10(11):. PubMed ID: 36363761 [No Abstract] [Full Text] [Related]
96. Biological and transcriptional studies reveal VmeL is involved in motility, biofilm formation and virulence in Liu PX; Zhang XY; Wang Q; Li YY; Sun WD; Qi Y; Zhou K; Han XG; Chen ZG; Fang WH; Jiang W Front Microbiol; 2022; 13():976334. PubMed ID: 36016795 [No Abstract] [Full Text] [Related]
97. Peptidomimetics as Potential Anti-Virulence Drugs Against Resistant Bacterial Pathogens. Martínez OF; Duque HM; Franco OL Front Microbiol; 2022; 13():831037. PubMed ID: 35516442 [TBL] [Abstract][Full Text] [Related]
98. A Structural Approach to Anti-Virulence: A Discovery Pipeline. McCarthy M; Goncalves M; Powell H; Morey B; Turner M; Merrill AR Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946116 [TBL] [Abstract][Full Text] [Related]
99. The Case against Antibiotics and for Anti-Virulence Therapeutics. Hotinger JA; Morris ST; May AE Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683370 [TBL] [Abstract][Full Text] [Related]
100. Virulence factors and quorum sensing as targets of new therapeutic options by plant-derived compounds against bacterial infections caused by human and animal pathogens. Kitpipit W; Scholfield CN; Sangkanu S; Nissapatorn V; Pereira ML; Paul AK; Mitsuwan W Vet World; 2023 Jun; 16(6):1346-1355. PubMed ID: 37577190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]